Correlation Between Nuwellis and Bone Biologics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Nuwellis and Bone Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nuwellis and Bone Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nuwellis and Bone Biologics Corp, you can compare the effects of market volatilities on Nuwellis and Bone Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nuwellis with a short position of Bone Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nuwellis and Bone Biologics.

Diversification Opportunities for Nuwellis and Bone Biologics

0.6
  Correlation Coefficient

Poor diversification

The 3 months correlation between Nuwellis and Bone is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding Nuwellis and Bone Biologics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bone Biologics Corp and Nuwellis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nuwellis are associated (or correlated) with Bone Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bone Biologics Corp has no effect on the direction of Nuwellis i.e., Nuwellis and Bone Biologics go up and down completely randomly.

Pair Corralation between Nuwellis and Bone Biologics

Given the investment horizon of 90 days Nuwellis is expected to generate 0.82 times more return on investment than Bone Biologics. However, Nuwellis is 1.21 times less risky than Bone Biologics. It trades about 0.23 of its potential returns per unit of risk. Bone Biologics Corp is currently generating about -0.06 per unit of risk. If you would invest  101.00  in Nuwellis on October 20, 2024 and sell it today you would earn a total of  20.00  from holding Nuwellis or generate 19.8% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Nuwellis  vs.  Bone Biologics Corp

 Performance 
       Timeline  
Nuwellis 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Nuwellis are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain basic indicators, Nuwellis exhibited solid returns over the last few months and may actually be approaching a breakup point.
Bone Biologics Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bone Biologics Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's essential indicators remain nearly stable which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Nuwellis and Bone Biologics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Nuwellis and Bone Biologics

The main advantage of trading using opposite Nuwellis and Bone Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nuwellis position performs unexpectedly, Bone Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bone Biologics will offset losses from the drop in Bone Biologics' long position.
The idea behind Nuwellis and Bone Biologics Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Other Complementary Tools

USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Equity Valuation
Check real value of public entities based on technical and fundamental data